Your email has been successfully added to our mailing list.

×
0 0 0 0 0 -0.0611430583264874 0.0796854829245395 -0.00246449947189283
Stock impact report

FDA declines to approve Intellipharma's opioid painkiller [Reuters]

INTELLIPHARMACEUTICS (IPCI) 
Last intellipharmaceutics earnings: 10/15 05:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.intellipharmaceutics.com
Company Research Source: Reuters
FDA declines to approve Intellipharma's opioid painkiller | Reuters Reuters Staff 1 Min Read Sept 25(Reuters) - Intellipharmaceutics International Inc said on Monday that the U.S. Food and Drug Administration declined to approve its long-acting opioid painkiller in its current form, backing its independent advisory panel that had raised concerns over the drug’s abuse-deterrence capabilities. The decision comes at a time when the United States is battling with the opioid abuse crisis, which claimed more than 33,000 people in 2015, according to the Centers for Disease Control and Prevention. The FDA asked Intellipharma to complete additional studies to assess the abuse-deterrent properties of the drug when used via oral and nasal methods, the company said. A panel of independent advisers to the FDA had voted 22-1 against approving the drug in July. (Reporting by Divya Grover in Bengaluru; Editing by Sriraj Kalluvila) All quotes delayed a minimum of 15 minutes. See here for a complete Show less Read more
Impact Snapshot
Event Time:
IPCI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for IPCI alerts
Opt-in for
IPCI alerts

from News Quantified
Opt-in for
IPCI alerts

from News Quantified